Joel Greenblatt Harmony Biosciences Holdings, Inc. Transaction History

Gotham Asset Management, LLC

$16.1 Billion
Q2 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 39,707 shares of HRMY stock, worth $1.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,707

Previous 23,163 71.42%

Holding current value

$1.03 Million

Previous $768,000 63.28%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$27.94 - $35.91 $462,239 - $594,095	16,544 Added 71.42%	39,707 $1.25 Million
Q1 2025 May 15, 2025	SELL	$32.18 - $40.46 $879,769 - $1.11 Million	-27,339 Reduced 54.13%	23,163 $768,000
Q4 2024 Feb 14, 2025	SELL	$31.86 - $41.49 $516,769 - $672,967	-16,220 Reduced 24.31%	50,502 $1.74 Million
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $548,490 - $730,405	-18,283 Reduced 21.51%	66,722 $2.67 Million
Q2 2024 Aug 14, 2024	BUY	$28.81 - $33.01 $36,790 - $42,153	1,277 Added 1.53%	85,005 $2.56 Million
Q1 2024 May 15, 2024	BUY	$29.93 - $35.06 $45,792 - $53,641	1,530 Added 1.86%	83,728 $2.81 Million
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $352,012 - $619,322	18,334 Added 28.71%	82,198 $2.65 Million
Q3 2023 Nov 14, 2023	SELL	$31.89 - $39.03 $281,843 - $344,947	-8,838 Reduced 12.16%	63,864 $2.09 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $1.37 Million - $1.68 Million	44,969 Added 162.15%	72,702 $2.56 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $854,176 - $1.5 Million	27,733 New	27,733 $905,000
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $827,909 - $1.09 Million	19,684 New	19,684 $872,000

Others Institutions Holding HRMY

# of Institutions

289

Shares Held

46.3M

Call Options Held

316K

Put Options Held

69.9K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.54B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account